International Society On Thrombosis And Haemostasis Inc
- Assets
- $20.6m
- Revenue
- $12.6m
- Investments
- $0.0
- Employees
- 38
- Location
- Carrboro, NC
- Founding
- 01/1975
- Data as of
- 12/2023
- EIN
- 23-7428305
Organization Overview
International Society On Thrombosis And Haemostasis Inc, operating under the name Isth, is located in Carrboro, NC. The organization was established in 1975. According to its NTEE Classification (H99) the organization is classified as: Medical Research N.E.C., under the broad grouping of Medical Research and related organizations. As of 12/2023, Isth employed 38 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Isth is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Isth generated $12.6m in total revenue. The organization has seen a slow decline revenue. Over the past 9 years, revenues have fallen by an average of (0.1%) each year. All expenses for the organization totaled $13.3m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
TO FURTHER RESEARCH & EDUCATION ON THE MAJOR DISEASE OF THROMBOSIS AND DISORDERS OF HAEMOSTASIS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTSIS XXXI CONGRESS AND 69TH MEETING OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE TOOK PLACE IN-PERSON (MONTREAL, CANADA) AND VIRTUALLY JUNE 24-28, 2023. THE SCIENTIFIC PROGRAM INCLUDED EXPERT PRESENTATIONS, EDUCATIONAL, POSTER, TECHNICAL, AND SSC SUBCOMMITTEE SESSIONS AS WELL AS SUBMISSION AND PRESENTATION OF ABSTRACTS. ISTH CONGRESSES ARE OPEN TO THE GLOBAL SCIENTIFIC COMMUNITY AND MANY OF THE PROCEEDINGS OF THE CONGRESS ARE AVAILABLE VIA OPEN ACCESS THROUGH THE SOCIETY'S JOURNAL AND WEBSITE.
PUBLICATION (HARDCOPY AND ONLINE) OF THE JOURNAL OF THROMBOSIS AND HAEMOSTASIS, WHICH SERVES AS AN INTERNATIONAL FORUM FOR ORIGINAL RESEARCH ARTICLES, REPORTS AND RECOMMENDATIONS AND REVIEWS RELATED TO THE IMPORTANT MEDICAL PROBLEMS OF THROMBOSIS, BLEEDING DISORDERS, AND VASCULAR BIOLOGY. TWELVE ISSUES ARE PUBLISHED ANNUALLY. PUBLICATION OF A MONTHLY E-NEWSLETTER PROVIDING INFORMATION ON ISTH EVENTS, EDUCATIONAL ACTIVITIES AND PROGRAMS, NEWS AND INTERVIEWS. COMPLEMENTING THE SOCIETY'S FLAGSHIP JOURNAL, THE JOURNAL OF THROMBOSIS AND HAEMOSTASIS (JTH) IS THE OPEN ACCESS ONLINE JOURNAL, RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (RPTH). RPTH IS A PLATFORM FOR SCIENCE AND DISCOURSE AMONG RESEARCHERS, CLINICIANS, NURSES, ALLIED HEALTH PROFESSIONALS, AND PATIENTS. PUBLISHED IN PARTNERSHIP WITH ELSEVIER, RPTH IS INTERESTED IN BASIC, CLINICAL, TRANSLATIONAL AND POPULATION OR PUBLIC HEALTH RESEARCH. MEMBER SERVICES PROVIDES BENEFITS TAILORED TO CLINICIANS, RESEARCHERS, NURSES, AND ALLIED HEALTH PROFESSIONALS AT ALL STAGES OF THEIR CAREERS IN BLEEDING AND CLOTTING DISORDERS THROUGH EDUCATION, PROGRAMS AND ACTIVITIES, AND PROFESSIONAL NETWORKING. THE SCIENTIFIC AND STANDARDIZATION COMMITTEE (SSC) IS A PERMANENT COMMITTEE OF THE ISTH AND IS ITS SCIENTIFIC WORKING ARM. CONDUCTED THROUGH SUBCOMMITTEES AND WORKING GROUPS, ITS ACTIVITIES PROMOTE COOPERATION AMONG LEADING INTERNATIONAL SCIENTISTS AND DIRECT THEIR ENERGIES TO PROJECTS THAT GENERATE RELIABLE AND STANDARDIZED CLINICAL AND BASIC SCIENCE TOOLS.
EDUCATION SYMPOSIA LED BY EXPERT MEMBERS IN INDUSTRIALIZED AND DEVELOPING COUNTRIES, FELLOWSHIPS AND TRAINING COURSES FOR EARLY CAREER PROFESSIONALS FROM BOTH INDUSTRIALIZED AND DEVELOPING COUNTRIES, WEBINARS, WEBCASTS AND ON-LINE COURSES DEVELOPED BY INTERNATIONALLY RECOGNIZED EXPERTS, SUPPORT FOR ABSTRACT PRESENTERS FROM DEVELOPING COUNTRIES TO ATTEND ANNUAL MEETINGS.
WORLD THROMBOSIS DAY (WTD) IS A WORLDWIDE INITIATIVE TO INCREASE GLOBAL AWARENESS OF BLOOD CLOTS, INCLUDING THEIR CAUSES, RISK FACTORS, SIGNS/SYMPTOMS, AND EVIDENCE-BASED PREVENTION AND TREATMENT. ULTIMATELY, WTD AIMS TO REDUCE DEATH AND DISABILITY CAUSED BY THROMBOTIC DISORDERS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
F Peyvandi President | OfficerTrustee | 2 | $0 |
P Angchaisuksiri President-El | OfficerTrustee | 2 | $0 |
S Schulman Treasurer | OfficerTrustee | 2 | $0 |
N Key Secretary Ge | OfficerTrustee | 2 | $0 |
M Carmen-Amigo Director | Trustee | 1 | $0 |
C Denis Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
The France Foundation Grant Prof. Ser | 12/30/19 | $812,903 |
Exponet Congress Event | 12/30/19 | $600,994 |
Weber Shandwick Pr&event Supp. | 12/30/19 | $303,323 |
Psav Total Inc Congress Event | 12/30/19 | $300,284 |
Apco Worldwide Ltd Pr&event Supp | 12/30/19 | $212,692 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $726,147 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,684,497 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,410,644 |
| Total Program Service Revenue | $9,509,868 |
| Investment income | $435,155 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $175,459 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $12,554,951 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $100,000 |
| Grants and other assistance to domestic individuals. | $3,366 |
| Grants and other assistance to Foreign Orgs/Individuals | $226,590 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $355,495 |
| Compensation of current officers, directors, key employees. | $127,940 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $3,201,197 |
| Pension plan accruals and contributions | $359,503 |
| Other employee benefits | $538,803 |
| Payroll taxes | $276,802 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $51,809 |
| Fees for services: Accounting | $12,600 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $192,493 |
| Fees for services: Other | $2,147,512 |
| Advertising and promotion | $0 |
| Office expenses | $69,623 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $32,616 |
| Travel | $822,150 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $4,141,440 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $57,251 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $13,329,163 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,007,302 |
| Savings and temporary cash investments | $652,394 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $1,593,031 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $2,131,410 |
| Net Land, buildings, and equipment | $552,423 |
| Investments—publicly traded securities | $14,290,699 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $390,462 |
| Total assets | $20,617,721 |
| Accounts payable and accrued expenses | $2,333,630 |
| Grants payable | $0 |
| Deferred revenue | $2,174,708 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $4,508,338 |
| Net assets without donor restrictions | $16,082,621 |
| Net assets with donor restrictions | $26,762 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $20,617,721 |
Grants Awarded
Over the last fiscal year, International Society On Thrombosis And Haemostasis Inc has awarded $100,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
THE UNIVERSITY OF UTAH PURPOSE: RSCH - PLATELETS | $50,000 |
UNIVERSITY OF NORTH CAROLINAAT CHAPEL HILL PURPOSE: RSCH - COAG PLATELET | $50,000 |